In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
The US Food and Drug Administration approved the marketing of 20 Zyn products to adults, the first time it has authorized ...
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...
The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...
Zyn is a pouch containing nicotine powder that is intended to rest in a user's mouth while the stimulant is absorbed into their bloodstream. The FDA's authorization of Zyn marks the first time ...
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...
After reviewing the scientific evidence, the agency has decided 20 ZYN nicotine pouch products can legally be sold in the US.
This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free ...